Full Coverage

UCB Receives Final EU Approval for Vimpat Epilepsy Drug

pharmiweb.co.uk
04-Sep-2008
        
Story Timeline:  92 days

Reuters Health - Sep. 04, 2008 BRUSSELS (Reuters) - Belgian pharmaceutical group UCB said on Wednesday that the European Commission has approved its new epilepsy drug Vimpat. In June, the European Medicines Agency gave approval for... [read full story]                    

Add Comment
Latest article on this story:

Vimpat (lacosamide) approved in Europe

 news-medical.net 04-Sep-2008
First article on this story:

Vimpat(R) Approved in Europe

 marketwire.com 03-Sep-2008
Selected publications with coverage of this story:
news-medical.net marketwire.com medicalnewstoday.com earthtimes.org pharmiweb.co.uk finanznachrichten.de
RELATED
Found 2 documents:
                   

UCB receives final EU approval for Vimpat epilepsy drug

finanznachrichten.de
03-Sep-2008
        

BRUSSELS, Sept 3 (Reuters) - Belgian pharmaceutical group UCB said on Wednesday that the European Commission has approved its new epilepsy drug Vimpat. In June, the European Medicines Agency gave approval for the...

                   

Vimpat(R) Approved in Europe

earthtimes.org
03-Sep-2008
        

BRUSSELS, BELGIUM -- First New Epilepsy Treatment for Partial-Onset Seizures in Three Years * A novel mode of action * Improved seizure control when added to a wide range of antiepileptic drugs * High long-term retention...